Literature DB >> 17607353

Chain-reaction Ca(2+) signaling in the heart.

Sandor Györke1, Brian M Hagen, Dmitry Terentyev, W Jonathan Lederer.   

Abstract

Mutations in Ca(2+) -handling proteins in the heart have been linked to exercise-induced sudden cardiac death. The best characterized of these have been mutations in the cardiac Ca(2+) release channel known as the ryanodine receptor type 2 (RyR2). RyR2 mutations cause "leaky" channels, resulting in diastolic Ca(2+) leak from the sarcoplasmic reticulum (SR) that can trigger fatal cardiac arrhythmias during stress. In this issue of the JCI, Song et al. show that mutations in the SR Ca(2+)-binding protein calsequestrin 2 (CASQ2) in mice result not only in reduced CASQ2 expression but also in a surprising, compensatory elevation in expression of both the Ca(2+)-binding protein calreticulin and RyR2, culminating in premature Ca(2+) release from cardiac myocytes and stress-induced arrhythmia (see the related article beginning on page 1814). In the context of these findings and other recent reports studying CASQ2 mutations, we discuss how CASQ2 influences the properties of Ca(2+)-dependent regulation of RyR2 and how this contributes to cardiac arrhythmogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17607353      PMCID: PMC1904329          DOI: 10.1172/JCI32496

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  Ca2+ scraps: local depletions of free [Ca2+] in cardiac sarcoplasmic reticulum during contractions leave substantial Ca2+ reserve.

Authors:  Thomas R Shannon; Tao Guo; Donald M Bers
Journal:  Circ Res       Date:  2003-06-05       Impact factor: 17.367

2.  Model of intracellular calcium cycling in ventricular myocytes.

Authors:  Y Shiferaw; M A Watanabe; A Garfinkel; J N Weiss; A Karma
Journal:  Biophys J       Date:  2003-12       Impact factor: 4.033

3.  Protein phosphatases decrease sarcoplasmic reticulum calcium content by stimulating calcium release in cardiac myocytes.

Authors:  Dmitry Terentyev; Serge Viatchenko-Karpinski; Inna Gyorke; Radmila Terentyeva; Sandor Gyorke
Journal:  J Physiol       Date:  2003-08-01       Impact factor: 5.182

4.  Calsequestrin mutant D307H exhibits depressed binding to its protein targets and a depressed response to calcium.

Authors:  Timothy D Houle; Michal L Ram; Steven E Cala
Journal:  Cardiovasc Res       Date:  2004-11-01       Impact factor: 10.787

Review 5.  A missense mutation in the CASQ2 gene is associated with autosomal-recessive catecholamine-induced polymorphic ventricular tachycardia.

Authors:  Michael Eldar; Elon Pras; Hadas Lahat
Journal:  Trends Cardiovasc Med       Date:  2003-05       Impact factor: 6.677

6.  Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death.

Authors:  Peter J Mohler; Jean-Jacques Schott; Anthony O Gramolini; Keith W Dilly; Silvia Guatimosim; William H duBell; Long-Sheng Song; Karine Haurogné; Florence Kyndt; Mervat E Ali; Terry B Rogers; W J Lederer; Denis Escande; Herve Le Marec; Vann Bennett
Journal:  Nature       Date:  2003-02-06       Impact factor: 49.962

7.  A missense mutation in CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel.

Authors:  Hadas Lahat; Elon Pras; Michael Eldar
Journal:  Ann Med       Date:  2004       Impact factor: 4.709

8.  Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores: Mechanism for hereditary arrhythmia.

Authors:  Dmitry Terentyev; Serge Viatchenko-Karpinski; Inna Györke; Pompeo Volpe; Simon C Williams; Sandor Györke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-16       Impact factor: 11.205

9.  Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia.

Authors:  Lei Song; Ronny Alcalai; Michael Arad; Cordula M Wolf; Okan Toka; David A Conner; Charles I Berul; Michael Eldar; Christine E Seidman; J G Seidman
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

10.  FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death.

Authors:  Xander H T Wehrens; Stephan E Lehnart; Fannie Huang; John A Vest; Steven R Reiken; Peter J Mohler; Jie Sun; Silvia Guatimosim; Long Sheng Song; Nora Rosemblit; Jeanine M D'Armiento; Carlo Napolitano; Mirella Memmi; Silvia G Priori; W J Lederer; Andrew R Marks
Journal:  Cell       Date:  2003-06-27       Impact factor: 41.582

View more
  6 in total

Review 1.  High- and low-calcium-dependent mechanisms of mitochondrial calcium signalling.

Authors:  András Spät; Gergo Szanda; György Csordás; György Hajnóczky
Journal:  Cell Calcium       Date:  2008-02-19       Impact factor: 6.817

2.  Functional characterization of CaVα2δ mutations associated with sudden cardiac death.

Authors:  Benoîte Bourdin; Behzad Shakeri; Marie-Philippe Tétreault; Rémy Sauvé; Sylvie Lesage; Lucie Parent
Journal:  J Biol Chem       Date:  2014-12-19       Impact factor: 5.157

3.  Sildenafil and FDP-Sr attenuate diabetic cardiomyopathy by suppressing abnormal expression of myocardial CASQ2, FKBP12.6, and SERCA2a in rats.

Authors:  Yu-si Cheng; De-zai Dai; Hui Ji; Qi Zhang; Yin Dai
Journal:  Acta Pharmacol Sin       Date:  2011-03-28       Impact factor: 6.150

4.  Subcellular Ca2+ signaling in the heart: the role of ryanodine receptor sensitivity.

Authors:  Benjamin L Prosser; Christopher W Ward; W J Lederer
Journal:  J Gen Physiol       Date:  2010-08       Impact factor: 4.086

Review 5.  Minding the calcium store: Ryanodine receptor activation as a convergent mechanism of PCB toxicity.

Authors:  Isaac N Pessah; Gennady Cherednichenko; Pamela J Lein
Journal:  Pharmacol Ther       Date:  2009-11-25       Impact factor: 12.310

Review 6.  Store-dependent deactivation: cooling the chain-reaction of myocardial calcium signaling.

Authors:  Przemysław B Radwański; Andriy E Belevych; Lucia Brunello; Cynthia A Carnes; Sándor Györke
Journal:  J Mol Cell Cardiol       Date:  2012-10-27       Impact factor: 5.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.